Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...
The risk associated with implantation of the implantable cardioverter-defibrillator (ICD) is often focused on the immediate complications of the procedure. The long-term risk of having an ICD, ...
Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced ...
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Implantable Cardioverter Defibrillators (ICD) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter ...
A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...
Heart failure is a deadly disease. Every year, tens of thousands of patients die from this condition, many of them suddenly. Efforts aimed at reducing mortality centered initially on antagonizing the ...
Short- and long-term risks of ventricular tachycardia or ventricular fibrillation, and of recurrent events, are related to the presence of transient or persistent physiological factors. Ventricular ...
A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback